InspireMD

InspireMD Dividend

Dividend of InspireMD (NSPR) as of Nov 19, 2026.

Dividend

0.00USD

Last updated:

How much dividend does InspireMD 2026 pay?

According to the latest status from November 2026, InspireMD paid a total of 0.00 USD per share in dividends within the last 12 months. With the current InspireMD price of 0.62 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical InspireMD Dividends

Historical InspireMD Dividends
PaydateDividend

The InspireMD Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
Jan 1, 2026 (e)
0.00 USD
Jan 1, 2027 (e)
0.00 USD
Jan 1, 2028 (e)
0.00 USD
The InspireMD Dividend history
YEARDividendYoY
est0.00USD—
est0.00USD—
est0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Is the InspireMD Dividend Safe?

InspireMD has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding InspireMD's Dividend Distributions

InspireMD’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining InspireMD's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

InspireMD's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in InspireMD’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

InspireMD Stock analysis

What does InspireMD do? InspireMD, Inc. generates revenue through the commercialization of its MicroNet stent platform technology, which includes the MicroNet micron mesh sleeve for embolic protection during stenting procedures. The company markets the CGuard carotid embolic prevention system (CGuard EPS), combining MicroNet with a self-expandable nitinol stent for carotid artery applications, and the MGuard Prime Embolic Protection System (MGuard Prime EPS) for acute coronary syndromes and saphenous vein graft interventions. In the European Union, InspireMD sells MGuard Prime EPS, a bare-metal cobalt-chromium stent, for coronary disease treatment. The company is also developing the neurovascular flow diverter NGuard for endovascular use. The primary buyers of InspireMD's products are healthcare providers, including hospitals and clinics specializing in vascular and coronary interventions. These institutions purchase the MicroNet, CGuard EPS, and MGuard Prime EPS to enhance procedural safety and outcomes during stent implantation. The European Union represents a key market for the MGuard Prime EPS, where it is marketed as a treatment option for coronary disease. The company's development of NGuard indicates a strategic focus on expanding its product portfolio into neurovascular applications. InspireMD's product segments are defined by clinical applications: carotid artery procedures (CGuard EPS), acute coronary syndromes (MGuard Prime EPS), and coronary disease treatment (MGuard Prime EPS in the EU). The MicroNet technology serves as a foundational component across multiple product lines, providing embolic protection. The company's revenue streams are driven by direct sales of these medical devices to healthcare institutions, with the EU market being a significant commercial focus for MGuard Prime EPS. InspireMD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InspireMD stock

InspireMD paid dividends every year for the past 0 years.

InspireMD is assigned to the 'Health' sector.

The dividends of InspireMD are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — InspireMD